Chemical Distribution: Three Attractive Markets
Desirable Markets - The area of life sciences covers nutrition, health and wellness of animals and humans. As such, several segments of this industry are attractive to chemical distributors, in...
View ArticlePartner for Peptides
Bachem is specialized in the process development and the manufacturing of peptides and complex organic molecules as active pharmaceutical ingredients (APIs), as well as innovative biochemicals for...
View ArticleBachem and GlyTech announce co-promotion agreement
Bachem and GlyTech announced that they have entered into a co-promotion agreement for GlyTech's glycosylation technology. As part of the agreement, Bachem will leverage its sales and marketing...
View ArticleBachem acquires American Peptide Company
Bachem announced today the forthcoming acquisition of American Peptide Company (APC), based in California. The Japanese seller ILS, a wholly-owned subsidiary of Otsuka Chemical, and the buyer, Bachem...
View ArticleTrends in Chemical & Pharmaceutical Research
Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs. Indeed, medicinal...
View ArticleAstraZeneca and Bicycle Therapeutics in Peptides Pact
Anglo-Swedish drugmaker AstraZeneca is collaborating with Bicycle Therapeutics to develop a novel class of small-molecule medicines for treating respiratory, cardiovascular and metabolic diseases. The...
View ArticleLonza Sells Belgian Peptides to PolyPeptide
Swiss specialty chemicals and biologics producer Lonza has agreed to sell its peptides business and operations in Braine-l’Alleud, Belgium, to PolyPeptide Laboratories Holding (PPL). Financial terms of...
View ArticleJanssen Gains Access to PeptiDream’s Technology
US drugmaker Janssen Pharmaceuticals has entered into a collaboration with Japanese biopharma PeptiDream. The deal, which gives Janssen access to PeptiDream’s peptide discovery platform system (PDPS),...
View ArticleBachem: Anne-Kathrin Stoller to assume CMO position as of 2018
Swiss biochemicals company Bachem announced that Dr. Anne-Kathrin Stoller will succeed Dr. José de Chastonay as Chief Marketing Officer of the organization on January 1, 2018. Dr. Chastonay will...
View ArticleInnovative Anti-Infectives
Natural products have been used since thousands of years for the treatment of a wide range of medical conditions in the form of traditional medicines. Today 60% of all new small molecule drugs are...
View Article
